Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of zinc supplementation on serum zinc levels in very low birth weight infants.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same author

Timing of food introduction and food-related allergic symptoms in childhood: Evidence from the Japan environment and Children's study (JECS).

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Temporal genetic changes in human bocavirus 1 in Fukushima, Japan, from 2018 to 2024.

Journal of medical microbiology·2026
Same author

Cornelia de Lange syndrome in an extremely low birth weight infant: a case report.

Fukushima journal of medical science·2026
Same author

Effects of external radiation dose on pediatric peripheral blood components after the Great East Japan Earthquake: Fukushima Health Management Survey.

Scientific reports·2026
Same author

Association between maternal bonding difficulty and neurodevelopmental delay in children aged 2 to 4 years: the Japan Environment and Children's Study.

Journal of developmental origins of health and disease·2026

Related Experiment Video

Updated: May 22, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

[Anti SSPE drugs].

Mitsuaki Hosoya1

  • 1Department of Pediatrics, Fukushima Medical University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 10, 2012
PubMed
Summary

Subacute sclerosing panencephalitis (SSPE) is a fatal neurological disorder. Intraventricular ribavirin therapy shows promise for eradicating the SSPE virus and halting disease progression, especially when initiated early.

Area of Science:

  • Neurovirology
  • Infectious Diseases
  • Pharmacology

Context:

  • Subacute sclerosing panencephalitis (SSPE) is a progressive, fatal central nervous system disorder caused by persistent SSPE virus infection.
  • Previous treatments like inosiplex and interferon-alpha showed limited efficacy.
  • Novel antiviral therapies are needed to combat SSPE.

Purpose:

  • To evaluate the potential of ribavirin as a novel antiviral chemotherapy for SSPE.
  • To determine if intraventricular administration of ribavirin can achieve effective concentrations in cerebrospinal fluid (CSF).
  • To explore the possibility of eradicating SSPE virus from the CNS.

Summary:

  • Ribavirin therapy has been proposed for SSPE.
  • Intraventricular administration of ribavirin can achieve CSF concentrations sufficient to completely inhibit SSPE virus replication.

Related Experiment Videos

Last Updated: May 22, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

  • This approach may eradicate the SSPE virus and halt disease progression.

    • Impact:

    • Intraventricular ribavirin therapy offers a potential strategy to stop the progression of SSPE syndrome.
    • Early-stage treatment evaluation is crucial for assessing the therapeutic efficacy of this novel approach.
    • This research could lead to a specific drug for SSPE, improving patient outcomes.